Literature DB >> 2424455

Characterization of histamine secretion induced by anthracyclines in rat peritoneal mast cells.

G Decorti, F Bartoli Klugmann, L Candussio, L Baldini.   

Abstract

The histamine-releasing activity of three anthracyclines, adriamycin, daunomycin and epirubicin, has been tested on rat peritoneal mast cells. The three drugs induced a marked and dose-dependent histamine secretion, in a noncytotoxic manner. The release was not sustained by extracellular calcium but was largely dependent on intracellular stores of this cation. This function was blocked by extremes of temperature (0 and 45 degrees), was very rapid and virtually complete within 10 sec. Treatment of mast cells with theophylline or disodium cromoglycate significantly reduced the secretory response to anthracyclines. On the basis of these results it is clear that the stimulant effect of anthracyclines is a true exocytotic response and thus is very similar to that of the classic mast cell secretagogue, compound 48/80.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424455     DOI: 10.1016/0006-2952(86)90724-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Evidence for the lack of involvement of free radicals in adriamycin-induced histamine release from rat peritoneal cells.

Authors:  L Candussio; F Bartoli Klugmann; G Decorti; L Baldini
Journal:  Agents Actions       Date:  1988-04

2.  Interaction of adriamycin with rat and mouse mast cells: histamine release and cellular uptake.

Authors:  G Decorti; F B Klugmann; L Candussio; L Baldini
Journal:  Agents Actions       Date:  1989-04

Review 3.  Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

Authors:  V B Pai; M C Nahata
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

4.  Effect of the carboxylic ionophore monensin on histamine release from rat peritoneal mast cells.

Authors:  G Decorti; F Bartoli Klugmann; E Crivellato; F Mallardi; L Candussio; L Baldini
Journal:  Agents Actions       Date:  1991-03

Review 5.  Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy.

Authors:  G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

6.  Study of the activation mechanism of adriamycin on rat mast cells.

Authors:  M D Estévez; M R Vieytes; L M Botana
Journal:  Agents Actions       Date:  1994-10

7.  Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.

Authors:  F B Klugmann; G Decorti; L Candussio; V Grill; F Mallardi; L Baldini
Journal:  Br J Cancer       Date:  1986-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.